Company Performance Metrics
Fluid Pharma develops proprietary powder-based drug delivery technologies and oral formulations that modify how medicines are delivered and experienced. The company focuses on taste-masking, controlled release, and gastro-intestinal targeting for small micro-pellets that can be incorporated into liquid suspensions, dispersible tablets, and animal
feed. Its MicroCoat technology is used to create age-appropriate and user-friendly oral therapies for patients with swallowing difficulties, including paediatric and geriatric populations. Fluid Pharma also develops products such as Tat-Fit, a taste-masked tamoxifen formulation that enables voluntary dosing in preclinical rodent research. The company operates through licensing, technology development, and partnerships with contract development and manufacturing organizations and research institutions to advance new therapies and preclinical dosing solutions.
